Glenview Trust’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $37.3M | Buy |
152,555
+785
| +0.5% | +$183K | 0.59% | 38 |
|
|
2025
Q4 | $31.4M | Buy |
151,770
+1,564
| +1% | +$309K | 0.48% | 44 |
|
|
2025
Q3 | $27.9M | Sell |
150,206
-589
| -0.4% | -$101K | 0.44% | 51 |
|
|
2025
Q2 | $23M | Buy |
150,795
+131
| +0.1% | +$20.1K | 0.4% | 54 |
|
|
2025
Q1 | $25M | Sell |
150,664
-2,720
| -2% | -$426K | 0.49% | 45 |
|
|
2024
Q4 | $22.2M | Sell |
153,384
-4,006
| -3% | -$621K | 0.42% | 57 |
|
|
2024
Q3 | $25.5M | Buy |
157,390
+252
| +0.2% | +$40.1K | 0.49% | 48 |
|
|
2024
Q2 | $23M | Sell |
157,138
-674
| -0.4% | -$100K | 0.46% | 46 |
|
|
2024
Q1 | $25M | Sell |
157,812
-1,850
| -1% | -$294K | 0.54% | 49 |
|
|
2023
Q4 | $25M | Buy |
159,662
+996
| +0.6% | +$153K | 0.61% | 44 |
|
|
2023
Q3 | $24.7M | Buy |
158,666
+860
| +0.5% | +$142K | 0.68% | 43 |
|
|
2023
Q2 | $26.1M | Buy |
157,806
+1,891
| +1% | +$305K | 0.71% | 40 |
|
|
2023
Q1 | $24.2M | Buy |
155,915
+499
| +0.3% | +$80.6K | 0.72% | 37 |
|
|
2022
Q4 | $27.5M | Buy |
155,416
+4,502
| +3% | +$777K | 0.91% | 31 |
|
|
2022
Q3 | $24.7M | Sell |
150,914
-1,599
| -1% | -$271K | 0.93% | 30 |
|
|
2022
Q2 | $27.1M | Buy |
152,513
+1,056
| +0.7% | +$188K | 0.99% | 25 |
|
|
2022
Q1 | $26.8M | Sell |
151,457
-40
| -0% | -$6.81K | 0.87% | 28 |
|
|
2021
Q4 | $25.9M | Buy |
151,497
+8,928
| +6% | +$1.46M | 0.86% | 33 |
|
|
2021
Q3 | $23M | Buy |
142,569
+984
| +0.7% | +$168K | 0.89% | 32 |
|
|
2021
Q2 | $23.3M | Buy |
141,585
+2,070
| +1% | +$343K | 0.9% | 33 |
|
|
2021
Q1 | $22.9M | Sell |
139,515
-8,397
| -6% | -$1.36M | 0.99% | 27 |
|
|
2020
Q4 | $23.3M | Sell |
147,912
-1,006
| -0.7% | -$148K | 1.08% | 25 |
|
|
2020
Q3 | $22.2M | Sell |
148,918
-209
| -0.1% | -$30.9K | 1.15% | 21 |
|
|
2020
Q2 | $21M | Sell |
149,127
-621
| -0.4% | -$90.5K | 1.19% | 20 |
|
|
2020
Q1 | $19.6M | Sell |
149,748
-1,391
| -0.9% | -$197K | 1.36% | 17 |
|
|
2019
Q4 | $22M | Sell |
151,139
-3,625
| -2% | -$492K | 1.23% | 23 |
|
|
2019
Q3 | $20M | Sell |
154,764
-2,238
| -1% | -$295K | 1.21% | 22 |
|
|
2019
Q2 | $21.9M | Sell |
157,002
-1,525
| -1% | -$211K | 1.36% | 19 |
|
|
2019
Q1 | $22.2M | Sell |
158,527
-3,210
| -2% | -$430K | 1.42% | 18 |
|
|
2018
Q4 | $20.9M | Buy |
161,737
+1,916
| +1% | +$267K | 1.54% | 15 |
|
|
2018
Q3 | $22.1M | Buy |
159,821
+1,555
| +1% | +$207K | 1.39% | 18 |
|
|
2018
Q2 | $19.2M | Sell |
158,266
-1,314
| -0.8% | -$164K | 1.43% | 19 |
|
|
2018
Q1 | $20.5M | Sell |
159,580
-2,399
| -1% | -$324K | 1.41% | 17 |
|
|
2017
Q4 | $22.6M | Sell |
161,979
-2,638
| -2% | -$367K | 1.56% | 15 |
|
|
2017
Q3 | $21.4M | Buy |
164,617
+5,317
| +3% | +$705K | 1.57% | 15 |
|
|
2017
Q2 | $21.1M | Sell |
159,300
-1,860
| -1% | -$237K | 1.64% | 9 |
|
|
2017
Q1 | $20.1M | Buy |
161,160
+3,265
| +2% | +$390K | 1.59% | 11 |
|
|
2016
Q4 | $18.2M | Buy |
+157,895
| New | +$18.2M | 1.51% | 15 |
|
|
2015
Q4 | $16.1M | Buy |
+156,867
| New | +$15.8M | 1.67% | 14 |
|
|
2014
Q4 | $17.2M | Buy |
+164,290
| New | +$17.3M | 1.83% | 12 |
|
|
2013
Q4 | $24.6M | Buy |
+268,385
| New | +$24.7M | 2.83% | 5 |
|
Other funds holding JNJ
VCM
VPM
Glenview Trust's JNJ Position: Q1 2026 in Review
Glenview Trust increased its Johnson & Johnson (JNJ) stake by 0.52% in Q1 2026, buying an estimated $183K and bringing the position to 152,555 shares worth $37.3M. The position accounts for 0.59% of the portfolio, ranked #38.
Glenview Trust first reported a position in JNJ in Q4 2013 and has held it in 41 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Glenview Trust held 152,555 shares of Johnson & Johnson worth $37.3M as of Q1 2026.
- Glenview Trust bought 785 Johnson & Johnson shares in Q1 2026, an estimated $183K.
- Johnson & Johnson made up 0.59% of Glenview Trust's portfolio in Q1 2026, its #38 holding.
- Glenview Trust first reported a position in Johnson & Johnson in Q4 2013 and has held it in 41 quarters since.
- 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.